> Detailanzeige

Bayart, Jean-Louis; Morimont, Laure; Closset, Mélanie; Wieërs, Grégoire; Roy, Tatiana; Gerin, Vincent; Elsen, Marc; Eucher, Christine; Van Eeckhoudt, Sandrine; Ausselet, Nathalie; David, Clara; Mullier, François; Dogné, Jean-Michel; Favresse, Julien; Douxfils, Jonathan

Confounding Factors Influencing the Kinetics and Magnitude of Serological Response Following Administration of BNT162b2

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel
  • Titel: Confounding Factors Influencing the Kinetics and Magnitude of Serological Response Following Administration of BNT162b2
  • Beteiligte: Bayart, Jean-Louis; Morimont, Laure; Closset, Mélanie; Wieërs, Grégoire; Roy, Tatiana; Gerin, Vincent; Elsen, Marc; Eucher, Christine; Van Eeckhoudt, Sandrine; Ausselet, Nathalie; David, Clara; Mullier, François; Dogné, Jean-Michel; Favresse, Julien; Douxfils, Jonathan
  • Erschienen: MDPI AG, 2021
  • Erschienen in: Microorganisms, 9 (2021) 6, Seite 1340
  • Sprache: Englisch
  • DOI: 10.3390/microorganisms9061340
  • ISSN: 2076-2607
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: Background: Little is known about potential confounding factors influencing the humoral response in individuals having received the BNT162b2 vaccine. Methods: Blood samples from 231 subjects were collected before and 14, 28, and 42 days following coronavirus disease 2019 (COVID-19) vaccination with BNT162b2. Anti-spike receptor-binding-domain protein (anti-Spike/RBD) immunoglobulin G (IgG) antibodies were measured at each time-point. Impact of age, sex, childbearing age status, hormonal therapy, blood group, body mass index and past-history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection were assessed by multivariable analyses. Results and Conclusions: In naïve subjects, the level of anti-Spike/RBD antibodies gradually increased following administration of the first dose to reach the maximal response at day 28 and then plateauing at day 42. In vaccinated subjects with previous SARS-CoV-2 infection, the plateau was reached sooner (i.e., at day 14). In the naïve population, age had a significant negative impact on anti-Spike/RBD titers at days 14 and 28 while lower levels were observed for males at day 42, when corrected for other confounding factors. Body mass index (BMI) as well as B and AB blood groups had a significant impact in various subgroups on the early response at day 14 but no longer after. No significant confounding factors were highlighted in the previously infected group.
  • Zugangsstatus: Freier Zugang